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Abstract
Enterovirus 71 (EV71) is one of the major causative agents of hand, foot, and mouth disease, a common febrile disease in
children; however, EV71 has been also associated with various neurological diseases including fatal cases in large EV71
outbreaks particularly in the Asia Pacific region. Recently we identified human P-selectin glycoprotein ligand-1 (PSGL-1) as a
cellular receptor for entry and replication of EV71 in leukocytes. PSGL-1 is a sialomucin expressed on the surface of
leukocytes, serves as a high affinity counterreceptor for selectins, and mediates leukocyte rolling on the endothelium. The
PSGL-1–P-selectin interaction requires sulfation of at least one of three clustered tyrosines and an adjacent O-glycan
expressing sialyl Lewis x in an N-terminal region of PSGL-1. To elucidate the molecular basis of the PSGL-1–EV71 interaction,
we generated a series of PSGL-1 mutants and identified the post-translational modifications that are critical for binding of
PSGL-1 to EV71. We expressed the PSGL-1 mutants in 293T cells and the transfected cells were assayed for their abilities to
bind to EV71 by flow cytometry. We found that O-glycosylation on T57, which is critical for PSGL-1–selectin interaction, is
not necessary for PSGL-1 binding to EV71. On the other hand, site-directed mutagenesis at one or more potential tyrosine
sulfation sites in the N-terminal region of PSGL-1 significantly impaired PSGL-1 binding to EV71. Furthermore, an inhibitor of
sulfation, sodium chlorate, blocked the PSGL-1–EV71 interaction and inhibited PSGL-1-mediated viral replication of EV71 in
Jurkat T cells in a dose-dependent manner. Thus, the results presented in this study reveal that tyrosine sulfation, but not O-
glycosylation, in the N-terminal region of PSGL-1 may facilitate virus entry and replication of EV71 in leukocytes.
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Introduction
Enterovirus 71 (EV71) is a small, nonenveloped, positive-
stranded RNA virus that belongs to human enterovirus species A
of the genus Enterovirus in the family Picornaviridae. EV71 is a major
causative agent of hand, foot, and mouth disease (HFMD), a
common febrile disease affecting mainly young children. HFMD is
characterized by a skin rash on the palms and soles, and ulcers on
the oral mucosa. HFMD due to EV71 and other enteroviruses is
usually mild and self-limited; however, EV71 infection may also
cause severe neurological diseases including polio-like paralysis
and fatal brainstem encephalitis in young children and infants
(reviewed in [1,2]). Over the last decade, many EV71 outbreaks
involving a number of fatal encephalitis cases have been reported
throughout the world, especially in the Asia-Pacific region,
including in Malaysia, Taiwan, Vietnam, and mainland China
[2,3,4].
Using an expression cloning method by panning with a cDNA
library from human Jurkat T cells, we recently identified human P-
selectin glycoprotein ligand-1 (PSGL-1) as a functional cellular
receptor for EV71 [5]. In addition, Yamayoshi et al. [6] identified
scavenger receptor class B, member 2 (SCARB2) as another
cellular receptor for EV71 by screening EV71-susceptible
transformants after transfecting mouse L929 cells with genomic
DNA from human RD rhabdomyosarcoma cells. SCARB2 is
ubiquitously expressed on a variety of tissues and cells [7], whereas
the tissue distribution of PSGL-1 is mainly limited to immune cells
such as leukocytes and dendritic cells [8]. We have also
demonstrated that some EV71 strains (PSGL-1–binding strain;
EV71-PB) use PSGL-1 as the primary and functional receptor for
infection of Jurkat T cells, but other EV71 strains (PSGL-1–non-
binding strain; EV71-non-PB) do not, suggesting phenotypic
differences in PSGL-1 usage among EV71 strains. Thus, the
identification of two distinct cellular receptors for EV71, PSGL-1
and SCARB2, has provided important clues in the elucidation of
the molecular basis of early virus-host interactions and pathogen-
esis of EV71. However, little is known about the biological
significance of the two EV71 receptors.
PSGL-1 is a sialomucin membrane protein that is expressed as a
homodimer comprised of two disulfide-linked subunits. Interaction
of PSGL-1 with selectins and chemokines is a key event during early
inflammationofimmunecells[8,9,10,11].TheN-terminalregionof
PSGL-1 is critical for PSGL-1 binding to P-, E- and L-selectins, and
post-translationalmodificationssuchasO-glycosylationandtyrosine
sulfationintheN-terminalregion of PSGL-1contribute theefficient
binding to selectins [12,13,14,15]. We have previously shown that
the N-terminal region of human PSGL-1 (amino acids 42–61)
containing a potential O-glycosylation residue (T57) and three
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responsible for PSGL-1 binding to EV71-PB [5]. Therefore, in the
present study, we investigated the involvement of post-translational
modificationsofPSGL-1inthebindingtoEV71-PB usingaseriesof
PSGL-1 mutants and an inhibitor of sulfation.
Tyrosine sulfation is an important late post-translational
modification of secreted and membrane-bound proteins expressed
in various mammalian cells and tissues and occurs in the trans-
Golgi network [16,17]. Tyrosine sulfated proteins have been
described in many mammalian species, and important roles for
tyrosine sulfation in protein-protein interactions have been widely
accepted, particularly for various chemokine receptors and their
ligands that mediate leukocyte migration during inflammation.
Furthermore, it has been well established that tyrosine sulfation of
the N-terminal region of the chemokine receptor, C-C chemokine
receptor 5 (CCR5), plays critical roles in the function of CCR5 as
a coreceptor for virus entry and replication of CCR5-tropic
human immunodeficiency virus type 1 (HIV-1) variants [18].
Here we demonstrate that tyrosine sulfation of the N-terminal
region of PSGL-1 facilitates PSGL-1–EV71 interaction and viral
replication of EV71-PB in Jurkat T cells. To our knowledge, this is
the second direct example of the involvement of tyrosine sulfation
in specific virus-receptor interactions, a modification that mediates
viral entry and replication in target cells.
Results
O-glycosylation at T57 of PSGL-1 is not necessary for
EV71-1095 binding
For binding to selectins, PSGL-1 requires post-translational
modifications with sialyl Lewis x-containing O-glycans at T57. a1,3-
fucosyltransferase (FUT7) is involved in the biosynthesis of sialyl
Lewis x determinants (Fig. 1A) [19,20]. Prevention of O-glycosyl-
ation by alanine substitution at T57 (T57A) eliminates binding of
PSGL-1 to P-selectin without affecting tyrosine sulfation [12]. First,
we generated and expressed a PSGL-1-T57A mutant (Fig. 1A) in
293T cells (293T/T57A) to examine the role of O-glycosylation on
T57 for PSGL-1 binding to EV71-1095, a representative strain of
EV71-PB [5]. As a positive binding control, we used a soluble form
of recombinant P-selectin (P-selectin-Fc). P-selectin-Fc did not bind
to any PSGL-1 transfectants in the presence of 2 mM EDTA
(Fig. 1B). P-selectin-Fc bound weakly to 293T cells transiently
expressing PSGL-1 (293T/PSGL-1) in the presence of Ca
2+ but not
to 293T/T57A cells (Fig. 1B). Double expression of PSGL-1 and
FUT7 in 293T cells resulted in the efficient binding of P-selectin-Fc
to PSGL-1 in a calcium-dependent manner (Fig. 1B). Even in the
presence of Ca
2+ and FUT7, P-selectin-Fc did not bind to 293T/
T57A cells (Fig. 1B). These observations are consistent with
previous findings that interaction of PSGL-1 with P-selectin is
calcium-dependent and requires appropriate O-glycosylation of
PSGL-1 at T57 [10,12]. In contrast, EV71-1095 showed marked
binding to 293T/PSGL-1 cells in a calcium-independent manner,
even in the absence of FUT7 (Fig. 1B). EV71-1095 also bound to
293T/T57A cells (Fig. 1B). These results indicate that, unlike the
interaction betweenPSGL-1and P-selectin,theinteraction between
PSGL-1andEV71-1095doesnotrequireCa
2+andtheO-glycansat
T57 of PSGL-1.
Sialic acids are not necessary for EV71-1095 binding
To examine the role of sialic acids on the cell surface, including
sialyl Lewis x moieties in the potential O-glycans at T44 and T57
of PSGL-1, on EV71 binding to 293T/PSGL-1 cells, we tested
EV71 binding to the cells pretreated with sialidase. Sialidase
treatment removed cell-surface sialyl Lewis x (Fig. 2A) and
reduced P-selectin-Fc binding to 293T/PSGL-1 cells (Fig. 2B). On
the other hand, EV71-1095 binding to the sialidase-treated cells
was not reduced regardless of the removal of sialyl Lewis x
(Fig. 2C). Although treatment with sialidase decreased EV71
infection to DLD-1 cells [21], sialic acids on the cell surface of
293T/PSGL-1 cells are not necessary for the binding of PSGL-1
to EV71-1095.
An inhibitor of sulfation reduces PSGL-1 binding to EV71-
PB
In addition to O-glycosylation of PSGL-1, sulfation of the three
tyrosines (Y46, Y48, and Y51) in the N-terminal region of PSGL-1
is required for high affinity binding to P- and L-selectins
[13,14,15,22,23]. To assess the role of tyrosine sulfation of
PSGL-1 in the PSGL-1–EV71 interaction, we treated 293T/
PSGL-1 cells with sodium chlorate, an inhibitor of sulfation that
blocks PSGL-1 binding to P-selectin [13]. As described previously,
sodium chlorate had no apparent effect on PSGL-1 expression on
the cell surface (Fig. 3A). On the other hand, sodium chlorate
reduced sulfated tyrosines on the cell surface (Fig. 3B) and
inhibited EV71-1095 binding to 293T/PSGL-1 cells in a dose-
dependent manner (Fig. 3C). These observations indicated that
sulfation of PSGL-1, in addition to its expression on the cell
surface, is important for EV71 binding.
One or more tyrosines in the N-terminal region of PSGL-1
are important for EV71-PB binding
We then determined the requirement for the putative sulfated
tyrosines (Y46, Y48, or Y51) in the N-terminal region of PSGL-1
for its binding to EV71-1095. We generated PSGL-1 mutants with
phenylalanine substitutions at one or more tyrosines and a mutant
with a deletion of this region (Fig. 4A). We transfected 293T cells
with expression plasmids containing the PSGL-1 mutants and used
them for the EV71 binding assay using flow cytometry. 293T cells
transfected with an empty vector expressed little or no detectable
tyrosine sulfated proteins on the cell surface (Fig. 4B). Similar to
the binding of PSGL-1 to P-selectin [13,14], substitution of the
tyrosines with phenylalanine prevented tyrosine sulfation and
Author Summary
Enterovirus 71 (EV71) is a major causative agent of hand,
foot, and mouth disease and a diverse array of neurolog-
ical diseases, including fatal encephalitis, in children. EV71
has increasingly caused large outbreaks of hand, foot, and
mouth disease particularly in the Asia-Pacific region.
Recently, we identified human P-selectin glycoprotein
ligand-1 (PSGL-1) as a functional receptor for EV71. PSGL-
1 on immune cells is a key molecule involved in early
inflammatory events and the PSGL-1–selectin interaction is
regulated by post-translational modifications of PSGL-1.
Here, we found that a post-translational modification,
tyrosine sulfation, at the N-terminal region of PSGL-1 is
critical for its binding to EV71 and subsequent viral
replication in lymphocytes. Important roles for tyrosine
sulfation in protein-protein interactions have been widely
accepted; however, involvement of tyrosine sulfation of
the receptor in the virus-receptor interaction has been
reported only for HIV-1. Therefore, this is the second and
unique example of the involvement of tyrosine sulfation in
specific virus-receptor interactions. Our results shed new
light on biological roles for tyrosine-sulfated proteins in
cell tropism and the pathogenesis of EV71.
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two tyrosines slightly reduced (Y46F) or impaired (Y48F, Y51F,
Y4648F, or Y4651F) the binding of PSGL-1 to EV71-1095
regardless of the apparent expression of tyrosine sulfated proteins
on the cell surface (Fig. 4B). Substitution of two or three tyrosines
(Y4851F or FFF) or deletion of the region (d46–51) reduced
tyrosine sulfated proteins on the cell surface and completely
disrupted the PSGL-1–EV71 interaction (Fig. 4B). We also
examined the role of tyrosine sulfation in PSGL-1 binding to
other EV71-PB strains. Binding of SK-EV006, C7/Osaka,
KED005, and 75-Yamagata strains to 293T/PSGL-1 cells was
also inhibited by sodium chlorate (Fig. S1). These strains bound to
293T/T57A cells but not to 293T cells expressing the PSGL-1-
FFF mutant. Taken together, these findings demonstrate that, in
contrast to O-glycosylation at T57, tyrosine sulfation of PSGL-1 is
essential for the efficient binding to EV71-PB strains.
Figure 1. PSGL-1 O-glycosylation at T57 is not necessary for binding to EV71-1095. (A) Schematic structure of the O-glycosylation of PSGL-
1 and the T57A mutant. FUT7 is involved in the synthesis of sialyl Lewis x. (B) 293T cells were transfected with the indicated expression plasmids.
Transfectants were incubated with P-selectin-Fc or EV71-1095 in the presence (Ca
2+) or absence (EDTA) of 2 mM CaCl2 followed by the P-selectin-Fc
or EV71 binding assay using flow cytometry. The percentage of cells bound to P-selectin-Fc or EV71-1095 is indicated in the upper right quadrant. The
data are representative of three independent experiments.
doi:10.1371/journal.ppat.1001174.g001
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cells
We next examined whether sulfation of PSGL-1 is required for
PSGL-1-dependent replication of EV71-PB in Jurkat T cells.
Jurkat T cells were infected with EV71 and cultured in the
presence of sodium chlorate to inhibit the sulfation of PSGL-1.
Sodium chlorate treatment did not affect PSGL-1 expression on
Jurkat T cells (Fig. 5A). On the other hand, sodium chlorate
significantly inhibited the replication of EV71-1095 in a dose-
dependent manner (Fig. 5B). The replication of other EV71-PB
strains was also inhibited in the presence of sodium chlorate
(Fig. 6). In contrast, replication of EV71-non-PB strains (EV71-
02362 and EV71-Nagoya), which can replicate in Jurkat T cells in
a PSGL-1-independent manner [5], was not affected by sodium
chlorate (Figs. 5C and 6). This observation supports that sodium
chlorate inhibited replication by blocking EV71-PB entry into the
cells. To confirm that sodium chlorate is acting at the receptor
level, we transfected Jurkat T cells with genomic RNA of EV71-
Figure 2. Effect of sialidase treatment on PSGL-1 binding to EV71-1095. (A) Sialyl Lewis x expression on the cell surface, as measured with
flow cytometry. The percentage of cells expressing sialyl Lewis x is indicated. (B) The cells were examined with the P-selectin-Fc binding assay using
flow cytometry. The percentage of cells bound to P-selectin-Fc is indicated in the upper right quadrant. (C) The cells were examined with the EV71
binding assay using flow cytometry. The percentage of cells bound to EV71-1095 is indicated in the upper right quadrant. As a negative control,
293T/PSGL-1 cells were incubated in the medium without sialidase. The data are representative of three independent experiments.
doi:10.1371/journal.ppat.1001174.g002
Figure 3. Effect of sodium chlorate on PSGL-1 binding to EV71-1095. Pretreatment of 293T/PSGL-1 cells with sodium chlorate reduces EV71-
1095 binding in a dose-dependent manner. (A) PSGL-1 expression on the cell surface, as measured with flow cytometry. As a negative control, 293T/
PSGL-1 cells cultured in the absence of sodium chlorate were stained with an isotype control antibody. (B) Sulfated tyrosines on the cell surface, as
measured with flow cytometry. As a negative control, 293T/PSGL-1 cells cultured in the absence of sodium chlorate were stained with an isotype
control antibody. (C) The cells were examined with the EV71 binding assay using flow cytometry. As a binding control, 293T/PSGL-1 cells were treated
with mock-infected culture supernatant. The data are representative of three independent experiments.
doi:10.1371/journal.ppat.1001174.g003
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PLoS Pathogens | www.plospathogens.org 4 November 2010 | Volume 6 | Issue 11 | e1001174Figure 4. Sulfated tyrosines in the N-terminal region of PSGL-1 are important for binding to EV71-1095. (A) Putative sites of tyrosine
sulfation (Y46, Y48, and Y51) in the N-terminus (aa 42–57) of PSGL-1 and the series of PSGL-1 mutants constructed. Identical and deleted amino acids
are indicated by dots (.) and dashes (–), respectively. (B) EV71-1095 binding to PSGL-1 mutants. The percentage of cells expressing tyrosine sulfated
proteins or bound to EV71-1095 is indicated in the upper right quadrant. The data are representative of three independent experiments.
doi:10.1371/journal.ppat.1001174.g004
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presence or absence of 30 mM sodium chlorate. Although
infectious viruses were recovered in the presence of sodium
chlorate, the mean viral titer in the presence of sodium chlorate
was over 10 times lower than that of the control experiments (data
not shown). Although sodium chlorate inhibited EV71-PB-binding
to PSGL-1 expressing cells (Figs. 3C and 5B (0 h postinfection)), we
could not rule out the possible involvement of the sodium chlorate
treatment during the later stages of viral replication. Further studies
are needed to elucidate the inhibitory mechanism of action of
sodium chlorate in a receptor dependent or independent manner
during different stages of viral replication of EV71.
Replication of the G-10 strain of coxsackievirus A16, which may
use another unidentified receptor(s) to infect Jurkat T cells [5,24],
was significantly inhibited by sodium chlorate (Fig. 6). This result
suggests that some sulfated molecules other than PSGL-1 might be
involved in the replication of coxsackievirus A16 in Jurkat T cells
in a PSGL-1-independent manner.
Discussion
We have shown that tyrosine sulfation, but not O-glycosylation,
of the N-terminal region of PSGL-1 is critical for EV71-PB
binding to PSGL-1 and for virus entry and subsequent replication
Figure 5. Effect of sodium chlorate on EV71-1095 replication in Jurkat T cells. (A) PSGL-1 expression on the Jurkat T cell surface, as
measured by flow cytometry. As a negative control, Jurkat T cells maintained in the absence of sodium chlorate were stained with an isotype control
antibody. (B) EV71-1095 growth kinetics in Jurkat T cells in the presence of sodium chlorate. Viral titers were determined at 0 h, 1 day, 2 days, 3 days,
and 4 days after EV71-1095 inoculation in Jurkat T cells. As a control for inhibition of EV71 replication, EV71-1095 growth kinetics in Jurkat T cells in
the presence of anti-PSGL-1 (KPL1) and control antibodies are shown. (C) EV71-02363 (EV71-non-PB) growth kinetics in Jurkat T cells in the presence
of sodium chlorate. Viral titers are indicated as the mean 6 S.D. of triplicate analyses. Asterisks indicate P,0.01 compared to those of the controls.
doi:10.1371/journal.ppat.1001174.g005
Figure 6. Replication of five EV71 strains and coxsackievirus A16 (CVA16) in Jurkat T cells in the presence of sodium chlorate. Viral
replication was determined in Jurkat T cells incubated with 30 mM sodium chlorate. EV71-PB strains are indicated in red. Titers are expressed as the
mean, and error bars indicate the S.D. of triplicate or quintuplicate (CVA16) analyses.
doi:10.1371/journal.ppat.1001174.g006
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bound to a PSGL-1 mutant with an alanine substitution at the
potential O-glycosylation site (T57) in a calcium-independent
manner (Figs. 1 and S1). Second, removal of sialyl Lewis x by
sialidase did not reduce PSGL-1 binding to EV71 (Fig. 2). Third, a
sulfation inhibitor, sodium chlorate, significantly impaired EV71-
PB binding to PSGL-1 in a dose-dependent manner (Figs. 3 and
S1). Fourth, EV71-PB binding to PSGL-1 was inhibited when
phenylalanine substitutions were made at one or more potential
tyrosine sulfation sites in the N-terminal region of PSGL-1 (Figs. 4
and S1). Finally, PSGL-1-dependent viral replication of EV71-PB
strains in Jurkat T cells, but not EV71-non-PB strains, was
inhibited by sodium chlorate (Figs. 5 and 6).
HumanPSGL-1isoneofthemostcharacterizedtyrosinesulfated
proteins at the molecular level [11]. The involvement of O-glycans
and sulfated tyrosines in the structural and functional basis of
PSGL-1 binding to its natural ligands has been extensively studied,
and distinct requirements for tyrosine sulfation for PSGL-1 binding
to selectins have been elucidated. Among the three potential
sulfatedtyrosinesofhumanPSGL-1,Y46andY51,butnotY48,are
important for PSGL-1 binding to L-selectin along with a core-2
based O-glycan with sialyl Lewis x at T57 [22]. On the other hand,
the crystal structure of the lectin and EGF domains of P-selectin co-
complexed with the N-terminal domain of PSGL-1 revealed a
critical involvement of sulfated tyrosines at Y48 and Y51 for direct
molecular contact with P-selectin [11]. The corresponding
interactions via sulfated tyrosines are not formed in E-selectin
binding in the crystal structure of the PSGL-1–E-selectin complex
[11]. Thus, tyrosine sulfation is critical for PSGL-1 binding to L-
and P-selectins, but not to E-selectin [14]. In our study, we have
shown that sulfated tyrosines at Y48 and Y51 play a critical role in
PSGL-1bindingto EV71-PB.However,O-glycosylationatT57and
sialyl Lewis x moieties on the potential O-glycans of PSGL-1 were
not required for the PSGL-1–EV71 interaction, suggesting distinct
structural requirements between EV71 and P-selectin for PSGL-1
binding. To elucidate the structural basis of the PSGL-1–EV71
interaction, further studies will be needed to identify genetic
determinants in EV71 capsid proteins required for PSGL-1 binding
using both EV71-PB and non-PB strains.
Yang et al. [21] have recently reported that EV71 may use
sialylated glycans as receptors for infection in intestinal DLD-1 cells.
Inourcurrentstudy,weshowedthat potentialO-glycansatT57and
sialic acids are not critical for binding to EV71-PB (Figs. 1 and 2).
However, our study does not exclude possible contributions of sialic
acids and other proteins with or without O-glycans on the cell
surface of various cells during the course of EV71 replication in a
PSGL-1-dependent or -independent manner [21,24,25].
In contrast to the structural requirements of O-glycans for PSGL-
1 binding to selectins, all three sulfated tyrosines, but not O-glycans
at T57, are required for PSGL-1 binding with the skin-associated
chemokine, CCL27 [9]. PSGL-1 facilitates P-selectin-mediated T
cell migration in the inflamed skin [26,27] and interacts with the
chemokine CCL27 to regulate skin-homing T cells [9]. HFMD
pathogenesis due to EV71 can be characterized as acute skin
inflammation.Therefore, itispossiblethatbinding of EV71-PB with
PSGL-1-positive skin-homing T cells and/or Langerhans cells, and
subsequent viralreplication in those cells, may participate in HFMD
pathogenesis and progression. The status of tyrosine sulfation of
PSGL-1 on those cells may modulate cell migration and PSGL-1-
dependent replication of EV71-PB in the inflamed skin.
An important role for tyrosine sulfation of a specific cellular
receptor in viral entry and replication has been demonstrated for
the first time in a co-receptor for HIV-1, CCR5 [18]. CCR5 is a
functional receptor for macrophage inflammatory protein (MIP)-
1a and MIP-1b, and is expressed on memory/effector T cells,
macrophages, and immature dendritic cells [28]. The N-terminal
region of CCR5 is highly modified by tyrosine sulfation and O-
glycosylation, and sulfated tyrosines play critical roles in CCR5
interactions with chemokines [18]. Site-directed mutagenesis and
treatment with sodium chlorate revealed that sulfation of tyrosine
residues in the N-terminal region of CCR5 is required for efficient
CCR5 binding to MIP-1a and MIP-1b, and to HIV-1 gp120-CD4
complexes, without affecting the expression of CCR5 [18].
Likewise, the efficacy of HIV-1 entry was significantly reduced
in cells expressing CCR5 mutants with one or more phenylalanine
substitutions at four potential tyrosine sulfated residues compared
to that in cells expressing native CCR5 [18]. Tyrosine sulfation
may be a common phenomenon in chemokine receptors expressed
on immune cells such as leukocytes, platelets, and dendritic cells
[16]. Therefore, tyrosine sulfation seems to regulate not only the
migration of immune cells but also the infectivity of viruses.
Although the occurrence of severe EV71 infection with a number
of fatal cases mainly in children continues to be a major public
health threat in the Asia Pacific region, no vaccines or antiviral
agents are currently available for EV71 [29]. Our data suggest that
the virus-receptor interaction may be a promising target for
potential antiviral agents. Thus, soluble PSGL-1 as one such agent
may have an inhibitory effect on EV71-PB replication [5]. In our
current study, we have demonstrated the possible involvement of
tyrosine sulfation of PSGL-1 on EV71 entry into target cells, and
accordingly, we showed the inhibitory effect of a tyrosine sulfation
inhibitor on viral replication of EV71-PB strains in Jurkat T cells.
Thus, the elucidation of the structural and functional basis of virus-
receptor interactions will provide novel and unique antiviral
approaches for the treatment of severe EV71-associated diseases.
Materials and Methods
Cells
293T cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM, Wako) supplemented with 10% fetal calf serum
(FCS). Jurkat T cells were maintained in RPMI medium (Sigma)
supplemented with 10% FCS.
Viruses
All EV71 strains (Table 1) and the coxsackievirus A16 prototype
strain (G-10) were propagated in RD or Vero cells. Because some
of the strains produced diffuse plaques on RD cells, the viral titers
were determined by a microtitration assay using 96-well plates and
Table 1. EV71 strains.
Strain
(Subgenogroup)
PSGL-1 binding
phenotype
1) Accession No. Reference
SK-EV006 (B3) PB AB059819 [33]
C7/Osaka (B4) PB AB059818 [33]
KED005
2) (C1) PB [33]
1095 (C2) PB AB059817 [30,34]
75-Yamagata (C4) PB AB177813 [35]
Nagoya (B1) Non-PB AB059813 [36]
02363 (C1) Non-PB AB115495 [34]
1)PB: PSGL-1–binding, Non-PB: PSGL-1–non-binding [5].
2)The VP1 nucleotide sequence of KED005 is identical to that of the 03784-MAA-
97 strain (accession no. AY207612) isolated in Malaysia [37].
doi:10.1371/journal.ppat.1001174.t001
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for each viral dilution, and the viral titers were expressed as 50%
cell culture infectious dose (CCID50). For flow cytometry, we used
concentrated viruses unless otherwise stated. To prepare virus
concentrations, viruses were ultracentrifuged, and the amount of
EV71 virions was measured.
Antibodies and recombinant proteins
The anti-EV71 monoclonal antibody (mAb) MA105 (mouse
IgG2b) was generated from mice immunized with EV71-1095 (Y.
Tano et al., unpublished data) Immunization to mice, fusion,
selection of hybridomas, and propagation of hybridomas in the
ascite fluid of the mice, were outsourced to Nippon Biotest
Laboratories Inc., Tokyo, Japan. The anti-human PSGL-1 mAb
KPL1 and anti-sialyl Lewis x mAb CSLEX1 were purchased from
BD Biosciences. Anti-human PSGL-1 mAb PL2 was purchased
from Beckman–Coulter. Anti-sulfotyrosine mAb Sulfo-1C-A2 [31]
was purchased from Millipore. For the negative control, mouse
IgG1 (MOPC-21) and IgG2a (G155–178) were purchased from
BioLegend and BD Biosciences, respectively. Recombinant P-
selectin-Fc was purchased from R&D Systems.
Plasmids and mutagenesis
For directional cloning using a CpoI recognition site [32], we
introduced a CpoI recognition-compatible (SanDI) site into the
pcDNA3.1(+) plasmid (Invitrogen). The BamHI-EcoRI fragment of
pcDNA3.1(+) was replaced with 59-ggatccgggtcccggtaagaattc-39
(BamHI+SanDI+gg+Stop+EcoRI) to produce pcDNA3.1SS. Hu-
man FUT7 cDNA was amplified from Jurkat T cell cDNA with
the primers FUT7-F1 (59-atacggtccggccatgaataatgctgggcacggc-39)
and FUT7-R1 (59-tgacggaccgtcaggcctgaaaccaaccct-39). The FUT7
ORF was sub-cloned into a SanDI site in pcDNA3.1SS to produce
pcDNA-FUT7. The sequence of the cloned FUT7 ORF was
identical to that of FUT7 (NM_004479).
The primers used for mutagenesis/deletion are provided in
Table S1. Briefly, cDNA of human SELPLG was cloned into
pEF6-Flag-3S [5] to produce pEF-PSGL-1 [5]. Mutations and
deletions were introduced into the N-terminal region of human
PSGL-1 with PCR, and the mutated SELPLG cDNA was cloned
into pEF6-Flag-3S.
Transfection of 293T cells
293T cells were transfected with expression plasmids using
Lipofectamine 2000 (Invitrogen), and DMEM medium was
replaced with fresh medium 4 h after transfection. The cells were
collected 24 h after transfection by pipetting, and were used for
flow cytometry. For inhibition of tyrosine sulfation of PSGL-1,
293T cells were treated with 10–50 mM sodium chlorate in
DMEM for 1 day. Four hours after transfection with pEF-PSGL-
1, the medium was replaced with medium containing sodium
chlorate, and the cells were further incubated for 20 h.
Flow cytometry
The cells were washed once with flow cytometry buffer (FC
buffer; PBS(2) supplemented with 2 mM EDTA, 2% FCS, and
0.1% NaN3) and incubated with the indicated mAb on ice for
30 min. After washing with FC buffer, the cells were incubated
with secondary antibodies conjugated with Alexa Fluor 488
(Invitrogen). To detect sialyl Lewis x, the cells were incubated with
secondary antibodies conjugated with R-phycoerythrin (South-
ernBiotech). To detect PSGL-1 by two-color flow cytometry, PL2
was labeled with a Zenon mouse IgG1 R-phycoerythrin labeling
kit (Invitrogen). To detect P-selectin-Fc binding, PBS(2) supple-
mented with 2 mM CaCl2, 2% FCS, and 0.1% NaN3 was used
instead of FC buffer. The cells were washed and analyzed with
FACSCalibur (Becton Dickenson).
EV71-binding assay by flow cytometry
293T cells (5610
5) transfected with the indicated expression
plasmid were washed once with FC buffer and incubated with the
EV71-1095 preparation (1610
7 CCID50) supplemented with 0.1%
NaN3, or concentrated viruses (containing 0.5 mg of VP1 protein)
per 50 ml FC buffer. The cells were washed and stained for 30 min
on ice with Alexa Fluor 488-conjugated MA105.
Sialidase treatment of cells
Cells were processed as in the EV71-binding assay and flow
cytometry described above. Prior to the addition of EV71, P-
selectin-Fc, or mAb, cells (2.5610
6) were incubated with 50 mU/
ml of Vibrio cholerae sialidase (Roche) in 500 ml of DMEM
supplemented with 2% FCS for 1 h at 37uC and then washed
once.
Viral infection assays
Jurkat T cells (4610
4 cells) were inoculated with viruses at 1
CCID50/cell for 1 h on ice, washed, and incubated in medium
(200 ml in a 48-well plate) at 34uC. For inhibition of tyrosine
sulfation of PSGL-1, the cells were pretreated with 10–30 mM
sodium chlorate in medium for more than 3 days, inoculated with
viruses, washed, and maintained in medium supplemented with
sodium chlorate. For mAb inhibition, the cells were pretreated
with 10 mg/ml mAb for 1 h, washed, and maintained in medium
with 10 mg/ml mAb. At the indicated time, the infected cells and
supernatants were freeze-thawed, and viral titers were determined
by CCID50 titration in RD cells. All infection assays were carried
out in triplicate unless otherwise stated, and the mean viral titers
were compared using Student’s t-test (two-tailed). P values,0.01
were considered statistically significant.
Supporting Information
Table S1 Substitution/deletion mutant primers.
Found at: doi:10.1371/journal.ppat.1001174.s001 (0.04 MB
DOC)
Figure S1 Binding of four EV71-PB strains to 293T cells
expressing PSGL-1. 293T cells were transfected with the indicated
expression plasmids (wild-type PSGL-1, T57A, or FFF) and
cultured in the absence (PSGL-1, T57A, and FFF) or presence
(PSGL-1+NaClO3) of 50 mM sodium chlorate. The transfectants
were incubated with concentrated EV71 and used for the EV71
binding assay using flow cytometry. As a negative control, cells
were incubated with concentrated supernatant from the RD cell
culture (RD sup.). The percentage of cells bound to EV71 is
indicated in the upper right quadrant.
Found at: doi:10.1371/journal.ppat.1001174.s002 (2.14 MB TIF)
Acknowledgments
The authors thank Dr. Nozomi Nishimura for preparing figures; Dr.
Haruko Shirato for providing cells; Junko Wada for excellent technical
assistance; Dr. Yuko Sasaki for helpful discussions; and Dr. Kevin Moore
(Oklahoma Medical Research Foundation) for useful advice.
Author Contributions
Conceived and designed the experiments: YN. Performed the experiments:
YN. Analyzed the data: YN TW HS. Contributed reagents/materials/
analysis tools: YN HS. Wrote the paper: YN TW HS.
Enterovirus 71 Binds to Tyrosine-Sulfated PSGL-1
PLoS Pathogens | www.plospathogens.org 8 November 2010 | Volume 6 | Issue 11 | e1001174References
1. Alexander JP Jr., Baden L, Pallansch MA, Anderson LJ (1994) Enterovirus 71
infections and neurologic disease–United States, 1977–1991. J Infect Dis 169:
905–908.
2. McMinn PC (2002) An overview of the evolution of enterovirus 71 and its
clinical and public health significance. FEMS Microbiol Rev 26: 91–107.
3. Bible JM, Pantelidis P, Chan PKS, Tong CYW (2007) Genetic evolution of
enterovirus 71: epidemiological and pathological implications. Rev Med Virol
17: 371–379.
4. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in
the People’s Republic of China in 2008. J Clin Microbiol 47: 2351–2352.
5. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, et al. (2009)
Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus
71. Nat Med 15: 794–797.
6. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, et al. (2009)
Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:
798–801.
7. Eskelinen EL, Tanaka Y, Saftig P (2003) At the acidic edge: emerging functions
for lysosomal membrane proteins. Trends Cell Biol 13: 137–145.
8. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, et al. (1996) P-
selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid,
and dendritic lineage and in some nonhematopoietic cells. Blood 88: 3010–3021.
9. Hirata T, Furukawa Y, Yang BG, Hieshima K, Fukuda M, et al. (2004) Human
P-selectin glycoprotein ligand-1 (PSGL-1) interacts with the skin-associated
chemokine CCL27 via sulfated tyrosines at the PSGL-1 amino terminus. J Biol
Chem 279: 51775–51782.
10. Sako D, Chang XJ, Barone KM, Vachino G, White HM, et al. (1993)
Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75:
1179–1186.
11. Somers WS, Tang J, Shaw GD, Camphausen RT (2000) Insights into the
molecular basis of leukocyte tethering and rolling revealed by structures of P-
and E-selectin bound to SLe
X and PSGL-1. Cell 103: 467–479.
12. Liu WJ, Ramachandran V, Kang J, Kishimoto TK, Cummings RD, et al. (1998)
Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required
for binding to P-selectin. J Biol Chem 273: 7078–7087.
13. Pouyani T, Seed B (1995) PSGL-1 recognition of P-selectin is controlled by a
tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 83: 333–343.
14. Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, et al.
(1995) A sulfated peptide segment at the amino terminus of PSGL-1 is critical for
P-selectin binding. Cell 83: 323–331.
15. Wilkins PP, Moore KL, McEver RP, Cummings RD (1995) Tyrosine sulfation of
P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin.
J Biol Chem 270: 22677–22680.
16. Kehoe JW, Bertozzi CR (2000) Tyrosine sulfation: a modulator of extracellular
protein-protein interactions. Chem Biol 7: R57–61.
17. Moore KL (2003) The biology and enzymology of protein tyrosine O-sulfation.
J Biol Chem 278: 24243–24246.
18. Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, et al. (1999)
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell
96: 667–676.
19. Natsuka S, Gersten KM, Zenita K, Kannagi R, Lowe JB (1994) Molecular
cloning of a cDNA encoding a novel human leukocyte a-1,3-fucosyltransferase
capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 269:
16789–16794.
20. Sasaki K, Kurata K, Funayama K, Nagata M, Watanabe E, et al. (1994)
Expression cloning of a novel a1,3-fucosyltransferase that is involved in
biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes.
J Biol Chem 269: 14730–14737.
21. Yang B, Chuang H, Yang KD (2009) Sialylated glycans as receptor and inhibitor
of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 6: 141.
22. Bernimoulin MP, Zeng XL, Abbal C, Giraud S, Martinez M, et al. (2003)
Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-
glycans and of tyrosine sulfate residue 51. J Biol Chem 278: 37–47.
23. Leppa ¨nen A, White SP, Helin J, McEver RP, Cummings RD (2000) Binding of
glycosulfopeptides to P-selectin requires stereospecific contributions of individual
tyrosine sulfate and sugar residues. J Biol Chem 275: 39569–39578.
24. Patel KP, Bergelson JM (2009) Receptors identified for hand, foot and mouth
virus. Nat Med 15: 728–729.
25. Lin YW, Wang SW, Tung YY, Chen SH (2009) Enterovirus 71 infection of
human dendritic cells. Exp Biol Med (Maywood) 234: 1166–1173.
26. Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, et al. (1997) P-selectin
glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds
to P-selectin and supports migration into inflamed skin. J Exp Med 185:
573–578.
27. Hirata T, Merrill-Skoloff G, Aab M, Yang J, Furie BC, et al. (2000) P-selectin
glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in
mediating T helper 1 lymphocyte migration. J Exp Med 192: 1669–1675.
28. Oppermann M (2004) Chemokine receptor CCR5: insights into structure,
function, and regulation. Cell Signal 16: 1201–1210.
29. Modlin JF (2007) Enterovirus de ´ja ` vu. N Engl J Med 356: 1204–1205.
30. Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, et al. (2002) Pyramidal
and extrapyramidal involvement in experimental infection of cynomolgus
monkeys with enterovirus 71. J Med Virol 67: 207–216.
31. Kehoe JW, Velappan N, Walbolt M, Rasmussen J, King D, et al. (2006) Using
phage display to select antibodies recognizing post-translational modifications
independently of sequence context. Mol Cell Proteomics 5: 2350–2363.
32. Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, et al. (2003) Kaposi’s
sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical
association and promoter-dependent transcriptional repression. J Virol 77:
1441–1451.
33. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999)
Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease
epidemics in Malaysia, Japan and Taiwan in 1997–1998. Jpn J Infect Dis 52:
12–15.
34. Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, et al. (2004) Molecular
epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr
Int 46: 231–235.
35. Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, et al. (2005) Frequent
importation of enterovirus 71 from surrounding countries into the local
community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol
43: 6171–6175.
36. Tagaya I, Tachibana K (1975) Epidemic of hand, foot and mouth disease in
Japan, 1972–1973: difference in epidemiologic and virologic features from the
previous one. Jpn J Med Sci Biol 28: 231–234.
37. Herrero LJ, Lee CSM, Hurrelbrink RJ, Chua BH, Chua KB, et al. (2003)
Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997–2000.
Arch Virol 148: 1369–1385.
Enterovirus 71 Binds to Tyrosine-Sulfated PSGL-1
PLoS Pathogens | www.plospathogens.org 9 November 2010 | Volume 6 | Issue 11 | e1001174